In vivo imaging refers to the visualization of various life processes within an organism. On the basis of this visualization, any abnormality prevailing within the biological systems can diagnosed as the presence of disease. With the increasing global burden of diseases, the demand for effective diagnosis and real time monitoring of treatment’s efficiency during the therapeutic period also increasing. This lead to the development of the in-vivo imaging techniques that facilitates better monitoring and diagnosis at molecular levels. In-vivo imaging techniques involves various technologically advanced paradigms that are used in diagnosis of various types of diseases such as cancer etc. In vivo imaging involves studying the cells’ interaction with the radioisotopes, biomarkers, luminescent proteins, or irradiations with electromagnetic radiations. On the basis of these interactions, the diagnosis and the treatment evaluation is done. Various techniques of in-vivo imaging includes techniques from PET (Positron Emission Tomography) to Diffuse Optical Tomography (DOT).
Key Players in the Global In vivo Imaging Market
Some of the key players profiled in the report are Bruker, MILabs B.V., FUJIFILM VisualSonics Inc., Mediso Ltd., LI-COR, Inc., Aspect Imaging., TRIFOIL IMAGING, MR Solutions, Biospace Lab S.A., and New England Biolabs.
Preclinical In vivo Imaging Market Segments
The global in vivo imaging market has been segmented on the basis of applications, techniques, and end users.
Based on the applications, the market has been segmented into nuclear imaging, optical imaging, and others.
Based on the techniques, the market has been segmented as radioisotopes based, biomarkers based, luminescent proteins based technique, and others.
Based on the end users, the market has been segmented as hospitals & clinics, imaging centers, research organizations, and others.
Request Customization
Get a Sample
Get a Sample
Request Customization